What Sante Ventures does

Santé Ventures is a healthcare and life sciences venture capital firm founded in 2006 and headquartered in Austin, Texas, with a second regional office in Boston. The firm invests in early-stage companies across three core verticals — Biotech, Medtech, and Healthtech — and has built a portfolio of more than 60 companies through five consecutive venture funds, with total assets under management exceeding $1 billion. Notable portfolio exits include LDR Medical (Zimmer Biomet), Explorys (IBM), AbVitro (Bristol Myers Squibb), Millipede Medical and Claret Medical and Farapulse (all Boston Scientific), TVA Medical (BD), and Laminar (Johnson & Johnson); the broader firm has been associated with over $70 billion in aggregate disclosed portfolio M&A value.

The firm's product surface extends beyond private venture investing. Santé Capital operates a systematic liquid hedge fund strategy powered by MindRank™, a proprietary big-data, machine-learning, and natural-language-processing platform built to identify mispriced publicly traded securities. Santé Accel is an internal startup studio that incubates and forms seed-stage medtech, biotech, and healthtech companies, with the explicit purpose of feeding later-stage investment into the main Santé Ventures funds. The firm has also added an in-house AI Engineer role in 2026 to integrate machine learning and explainable AI into investment decision-making across both venture and public-equity strategies.

Santé generates revenue primarily through management fees on committed capital across its five venture funds, supplemented by carried interest from successful exits. The hedge fund arm generates management and performance fees from institutional LPs, family offices, and accredited investors. Deal flow is sourced through direct relationships with founders and through deep institutional partnerships with Stanford Biodesign, Mayo Clinic, Cleveland Clinic Innovations, and Mass General Brigham, while exits are facilitated by longstanding relationships with strategic acquirers across the healthcare universe. Fund V closed at $330 million in February 2026 — the firm's largest fund to date — and the limited partner base is described as expanded and diversified across domestic and international markets.

Name

Sante Ventures

Legal name

Santé Ventures

Website

https://sante.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Santé Ventures is an Austin-based healthcare and life sciences venture capital firm founded in 2006, managing over $1B across five funds and 60+ portfolio companies in Biotech, Medtech, and Healthtech, complemented by a systematic hedge fund (Santé Capital) and an internal startup studio (Santé Accel).

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Other Financial Vehicles (525990), Other Investment Pools and Funds (5259)

akta.pro primary industry

Secondary Venture Funds (VC Secondaries) (FSANAAAK)

akta.pro secondary industry

Venture Debt Providers (FSANAAAL)

Keywords

• Healthcare venture capital
• Life sciences investing
• Medical device investment
• Biotech early-stage funding
• Systematic hedge fund

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Venture Capital Fund Management: Generates revenue through management fees and carried interest from limited partners across five venture capital funds focused on early-stage healthcare and life sciences investments; Fund V closed at $330M in February 2026 exceeding $300M target, with total AUM over $1B.
2. Santé Capital Systematic Hedge Fund: Systematic liquid hedge fund investment strategy utilizing MindRank™ proprietary software; generates risk-adjusted returns from mispriced publicly traded securities through quantitative models combining big data, machine learning, and natural language processing.

Go-to-market motion1 record

Distribution channels3 records

Core offering

Santé Ventures is a healthcare and life sciences venture capital firm that invests in early-stage private companies across Biotech, Medtech, and Healthtech verticals, managing over $1 billion in capital across five venture funds and 60+ portfolio companies. Through its subsidiary Santé Capital, the firm also operates a systematic liquid hedge fund strategy using its proprietary MindRank™ AI/ML/NLP software to capture mispricing in publicly traded securities, and runs Santé Accel, a startup studio that incubates seed-stage opportunities.

Product overview

Santé Ventures operates a multi-strategy investment partnership combining two primary service lines: a private venture capital arm (Santé Ventures) that invests in early-stage Biotech, Medtech, and Healthtech companies, and a public securities arm (Santé Capital) that runs a systematic quantitative strategy powered by the proprietary MindRank™ software platform. The architecture pairs external capital deployment with an internal technology backbone: MindRank™ — built on big data, machine learning, and natural language processing — drives Santé Capital's liquid hedge fund strategy, while the venture side of the firm is supported by Santé Accel, a startup studio that incubates seed-stage medtech, biotech, and healthtech companies in preparation for follow-on investment from the main Santé Ventures funds. Together, these offerings reflect a unified platform where proprietary AI-driven investment technology and human-led company creation reinforce the firm's broader thesis of identifying innovative healthcare companies addressing unmet medical needs.

Differentiator

Problem solved

Functional benefit

Brands

• Santé Capital: Publicly traded securities investment arm using the proprietary MindRank™ systematic quantitative strategy built on big data, machine learning, and natural language processing
• Santé Accel

Products and services

• Santé Ventures (Private Venture Capital) Private investment vehicle deploying capital into innovative early-stage healthcare companies with a focus in Biotech, Medtech, and Healthtech. Manages over $1 billion in capital across five venture funds and 60+ portfolio companies. Targeted at founders and institutional limited partners.
• Santé Capital (Systematic Liquid Hedge Fund) Public securities strategy utilizing a systematic quantitative investment approach built on the proprietary MindRank™ software to generate risk-adjusted returns in mispriced publicly traded securities. Distributed to institutional LPs, family offices, and accredited investors via the firm's in-house capital formation team.
• Santé Accel (Startup Studio) Santé start-up studio focused on creating and fostering seed-stage medtech, biotech, and healthtech opportunities through incubation, company formation, talent matching, and coaching, preparing companies for follow-on investment from Santé's main funds.
• Santé Ventures Fund V Fifth and largest venture fund of Santé Ventures, closed with $330 million in committed capital, focused on early-stage investments in biotechnology, medical technology, and digitally enabled healthcare companies addressing unmet medical needs.

Quantifiable outcome

• $70 billion+ in combined acquisition value for three portfolio companies Louis Bock guided (SeaGen/Pfizer $43B, Horizon Therapeutics/Amgen $27B, Zogenix/UCB $2B)
• +4 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Longitude Capital: Healthcare-dedicated growth and venture firm investing in biotech, medtech, and healthtech; similar fund size, sector focus, and growth-stage orientation to Santé Ventures Funds III–V.
• RA Capital Management: Healthcare-focused crossover fund that invests across public and private biotech and medtech; comparable to Santé's dual private venture + public systematic strategy and similar size/AUM profile.
• Versant Ventures: Healthcare-focused venture firm investing across biotech, medtech, and healthtech with offices in the US, Canada, and Europe; comparable fund size, sector mix, and company-creation approach to Santé.
• Atlas Venture: Early-stage biotech-focused venture firm that builds companies from inception in a model analogous to Santé Accel; comparable seed/Series A orientation, though with heavier biotech weighting and smaller fund sizes.
• Bain Capital Life Sciences: Dedicated life sciences platform within Bain Capital investing across biotech, medtech, and pharma services; co-investor with Santé (e.g., Apreo Health) and a directly comparable scaled healthcare specialist.
• OrbiMed: Healthcare-dedicated investment firm managing roughly $17B across private equity, growth equity, and public equity strategies spanning biotech, medtech, and diagnostics — directly comparable to Santé's combined Santé Ventures + Santé Capital platform.
• Frazier Healthcare Partners: Dedicated healthcare venture and growth firm investing across biotech, medtech, and pharma services with multiple sequential funds — closest peer in fund size, sector mix, and growth-stage focus.
• 5AM Ventures: Early-stage life sciences venture firm investing in biotech and medtech with multiple sequential funds; closely comparable in fund size, sector focus, and operational value-add model.

Broad incumbents

• ARCH Venture Partners: Large, established healthcare and technology venture firm with multiple billion-dollar funds and broad biotech/medtech exposure; comparable thesis area but materially larger and more biotech-skewed than Santé.
• New Enterprise Associates (NEA): Multi-stage venture firm with a dedicated healthcare practice investing across biotech, medtech, and healthtech; broader sector mandate than Santé but directly competitive for the same Series A/B healthcare rounds.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sante-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles28 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments118 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sante Ventures